Injectable slow acting anaesthetic can banish prolonged pain
April 16th, 2009 - 3:42 pm ICT by IANS ( Leave a comment )New York, April 16 (IANS) Paediatric researchers have developed a slow-acting anaesthetic that could banish prolonged pain during and after surgery.
Researchers used specially designed fat-based particles called liposomes to package saxitoxin, a potent anaesthetic. They then produced a long-lasting local anaesthesia in rats minus apparent toxicity to nerve or muscle cells.
“The idea was to have a single injection that could produce a nerve block lasting days, weeks, maybe even months,” explained Daniel Kohane, of critical care medicine in the Department of Anaesthesiology at Boston Children’s Hospital, and study co-author.
“It would be useful for conditions like chronic pain where, rather than use narcotics, which are systemic and pose a risk of addiction, you could just put that piece of the body to sleep, so to speak.”
Previous attempts to develop slow-release anaesthetics have been unsuccessful due to the tendency for conventional anaesthetics to cause toxicity to the surrounding tissue.
Indeed, drug packaging materials have themselves been shown to cause tissue damage. Now, Kohane and colleagues reported that if saxitoxin is packaged within liposomes, it is able to block nerve transmission of pain without causing significant nerve or muscle damage.
In lab experiments, the researchers evaluated various formulations - different types of liposomes containing saxitoxin with or without dexamethasone, a potent steroid known to augment the action of encapsulated anaesthetics.
The best liposomes produced nerve blocks lasting two days if they contained saxitoxin alone and seven days if combined with dexamethasone. Cell culture experiments and tissue analysis confirmed that the formulations were not toxic to muscle or nerve cells, said a Boston release.
“If these long-acting, low-toxicity formulations of local anesthetics are shown to be effective in humans, they could have a major impact on the treatment of acute and chronic pain,” said Alison Cole of the National Institute of General Medical Sciences.
The study was published online by the Proceedings of the National Academy of Sciences.
- Anaesthesia jabs promise prolonged pain relief without toxicity - Apr 16, 2009
- New anaesthetic approach blocks pain without interfering with motor function - Feb 02, 2010
- Re-engineered toxins can treat asthma, arthritis - Jan 02, 2012
- New invention could improve cancer drug delivery - Dec 24, 2010
- Chilling out does promote obesity - Dec 02, 2011
- Stem cells bulk up muscle, halt ageing - Nov 11, 2010
- Could Botox get rid of cold sores? - Nov 23, 2010
- New treatment could help minimize nerve damage in spinal cord injuries - May 04, 2011
- Healing damaged liver tissues - Dec 05, 2011
- Placing ice on injury may prevent healing - Oct 27, 2010
- Achilles heel of chronic inflammatory pain uncovered - Aug 18, 2010
- Stem cell revolution can defeat Alzheimer's - Jun 05, 2011
- Burning more sugar drives super athleticism - Dec 01, 2011
- Why injured areas turn sensitive even to soft touch - Nov 16, 2009
- Nanoscale whiskers from sea squirts could grow human muscle tissue - Mar 12, 2011
Tags: anaesthesiology, anaesthetic, anaesthetics, boston children, cell culture, critical care medicine, dexamethasone, kohane, lab experiments, local anaesthesia, local anesthetics, muscle cells, muscle damage, nerve block, nerve blocks, nerve cells, nerve transmission, packaging materials, s hospital, tissue analysis